84
Participants
Start Date
August 31, 2001
Primary Completion Date
January 31, 2005
celecoxib
cisplatin
fluorouracil
brachytherapy
radiation therapy
State University of New York Health Science Center at Brooklyn, Brooklyn
New York Methodist Hospital, Brooklyn
Western Pennsylvania Hospital, Pittsburgh
Bryn Mawr Hospital, Bryn Mawr
Mercy Fitzgerald Hospital, Darby
Delaware County Memorial Hospital, Drexel Hill
CCOP - MainLine Health, Wynnewood
Lankenau Cancer Center at Lankenau Hospital, Wynnewood
Regional Radiation Oncology Center at Rome, Rome
Akron General Medical Center, Akron
Akron City Hospital - Summa Health System, Akron
West Michigan Cancer Center, Kalamazoo
CCOP - Marshfield Clinic Research Foundation, Marshfield
Methodist Medical Center of Illinois, Peoria
CCOP - Kansas City, Kansas City
Memorial Hospital Cancer Center, Colorado Springs
LDS Hospital, Salt Lake City
Dixie Regional Medical Center, St. George
Foundation for Cancer Research and Education, Phoenix
CCOP - Southern Nevada Cancer Research Foundation, Las Vegas
Mills-Peninsula Health Services, Burlingame
Sutter Health Western Division Cancer Research Group, Greenbrae
Mobile Infirmary Medical Center, Mobile
UCSF Comprehensive Cancer Center, San Francisco
Baptist Hospital of Miami, Miami
Ball Memorial Hospital Cancer Center, Muncie
Methodist Hospital Cancer Center at Nebraska Methodist Hospital - Omaha, Omaha
Monmouth Medical Center, Long Branch
South Jersey Regional Cancer Center, Millville
Fox Chase Virtua Health Cancer Program at Virtua Memorial Hospital, Mount Holly
Newark Beth Israel Medical Center, Newark
Community Medical Center, Toms River
Comprehensive Cancer Center at Wake Forest University, Winston-Salem
Paoli Memorial Hospital, Paoli
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia, Philadelphia
University of Texas - MD Anderson Cancer Center, Houston
National Cancer Institute (NCI)
NIH
Radiation Therapy Oncology Group
NETWORK